{"id":"W4362730611","doi":"10.21037/tlcr-22-723","title":"Adjuvant therapies in stages I–III epidermal growth factor receptor-mutated lung cancer: current and future perspectives","year":2023,"lang":"en","type":"review","venue":"Translational Lung Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; Foundation Medicine; Provincial Health Services Authority; Regeneron Pharmaceuticals; F. Hoffmann-La Roche; Daiichi Sankyo Europe; Sanofi; Chugai Pharmaceutical; Daiichi-Sankyo; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Lung cancer; Epidermal growth factor receptor; Oncology; Internal medicine; Cancer; Stage (stratigraphy); Chemotherapy; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000469191,0.0005614326,0.001516363,0.001022708,0.0003174734,0.00009176206,0.0002135951,0.0002947575,0.001016238],"category_scores_gemma":[0.00002822314,0.0004251265,0.0003161256,0.001477852,0.0002726482,0.0002199903,0.00004895474,0.001487047,0.00001092963],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001631695,"about_ca_system_score_gemma":0.003843821,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002244249,"about_ca_topic_score_gemma":0.000919984,"domain_scores_codex":[0.9958555,0.0004515251,0.000724229,0.0009722677,0.00122247,0.0007740612],"domain_scores_gemma":[0.9981168,0.0005925578,0.0001628301,0.0002752851,0.0005744402,0.0002781185],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002729887,0.0002860317,0.009296209,0.03757704,0.003182764,0.00006249334,0.01381292,0.0000103503,0.000007430855,0.002140554,0.003349006,0.9300022],"study_design_scores_gemma":[0.004682878,0.0001580468,0.02215433,0.03395391,0.002083871,0.00001771801,0.00152276,0.0002009002,0.00000530109,0.0001867472,0.9341056,0.0009279207],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009099007,0.9871835,0.00000941811,0.004605862,0.0004722237,0.003760087,0.00281628,0.0001047409,0.0001380651],"genre_scores_gemma":[0.00089409,0.9924697,0.00007867363,0.00001545075,0.001441222,0.003021822,0.0009713683,0.0001455193,0.00096217],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9307566,"threshold_uncertainty_score":0.9998969,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1039491511596937,"score_gpt":0.5075621218298284,"score_spread":0.4036129706701347,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}